Zeba Siddiqui

India’s Ranbaxy gets FDA approval for Novartis’s Diovan generic

August 25, 2021 at 6:06 a.m.

WASHINGTON/MUMBAI (Reuters) - India's Ranbaxy Laboratories Ltd has received approval from the U.S. Food and Drug Administration (FDA) to launch a cheaper copy of Novartis AG's blood pressure pill Diovan,...

India’s Ranbaxy gets FDA approval for Novartis’s Diovan generic

May 14, 2019 at 6:12 a.m.

India’s Sun Pharma plans gradual phase-out of Ranbaxy-branded drugs in U.S.: sources

August 25, 2021 at 3:51 a.m.

MUMBAI (Reuters) - India's Sun Pharmaceutical Industries Ltd plans to begin phasing out sales of generic drugs branded as Ranbaxy Laboratories Ltd products in the United States, after completing a...

India’s Sun Pharma plans gradual phase-out of Ranbaxy-branded drugs in U.S.: sources

May 14, 2019 at 5:52 a.m.

MUMBAI (Reuters) - India's Sun Pharmaceutical Industries Ltd plans to begin phasing out sales of generic drugs branded as Ranbaxy Laboratories Ltd products in the United States, after completing a...

India regulator examines Sun, Ranbaxy merger trading: source

August 25, 2021 at 3:52 a.m.

MUMBAI (Reuters) - India's market regulator will ask Ranbaxy Laboratories and Sun Pharmaceutical Industries for more information about their planned $3.2 billion merger and seek trading data from stock exchanges...

India’s drug inspectors hard-pressed to scrutinize factories

May 14, 2019 at 5:51 a.m.

MUMBAI (Reuters) - An Indian drugs regulator is among the first to admit that oversight of the nation's huge pharmaceutical industry can be patchy. G.L. Singhal, chief regulator of northern...

FDA bans imports from Sun Pharma plant in India crackdown

May 14, 2019 at 5:43 a.m.

MUMBAI (Reuters) - The U.S. Food and Drug Administration (FDA) has banned imports from Indian generic drugmaker Sun Pharmaceutical Industries Ltd's plant at Karkhadi in the western state of Gujarat,...

Ranbaxy recalls some batches of generic Lipitor in latest quality blow

August 25, 2021 at 2:41 a.m.

MUMBAI (Reuters) - Indian drugmaker Ranbaxy Laboratories Ltd, reeling under a flurry of regulatory rebukes due to manufacturing quality concerns, has recalled more than 64,000 bottles of the generic version...

Ranbaxy recalls some batches of generic Lipitor in latest quality blow

May 14, 2019 at 5:41 a.m.

Wockhardt Ltd.'s Ace Proxyvon tablets are arranged for a photograph in Mumbai, India, on Thursday, Feb. 20, 2014. The U.S. is increasing scrutiny of generic drugs made in India, and in the past nine months banned imports from four plants belonging to Ranbaxy Laboratories Ltd. and Wockhardt Ltd.

U.S. fears for patents on next-generation drugs in India

November 4, 2021 at 1:20 a.m.

NEW DELHI/MUMBAI (Reuters) - The United States on Thursday voiced concern over protection of patents on safer and more effective next-generation medicines in India amid fears that authorities are considering...

All Stories